Literature DB >> 3681705

Actions of neuropeptide Y on innervated and denervated rat tail arteries.

T O Neild1.   

Abstract

1. Neuropeptide Y caused a dose-dependent contraction and depolarization of the smooth muscle of the rat tail artery. 2. 30 nM-neuropeptide Y increased the contraction caused by either nerve-released noradrenaline or smooth muscle action potentials. 3. 30 nM-neuropeptide Y did not change the amplitude or rate of rise of the smooth muscle action potential. It did not change the amplitude of small excitatory junction potentials, suggesting that it did not affect neurotransmitter release. 4. 30 nM-neuropeptide Y increased the contraction caused by exogenous noradrenaline, 5-hydroxytryptamine and K in concentrations that gave submaximal contractions. It did not affect the response to higher concentrations that gave maximal or near-maximal contractions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3681705      PMCID: PMC1192447          DOI: 10.1113/jphysiol.1987.sp016519

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  28 in total

1.  Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

Authors:  M J Mulvany; W Halpern
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

Review 2.  Electrical changes in the membrane in junctional transmission.

Authors:  B L Ginsborg
Journal:  Biochim Biophys Acta       Date:  1973-11-28

3.  Comparison of angiotensin converting enzyme inhibitors captopril and MK421-diacid in guinea pig atria.

Authors:  A Nakashima; J A Angus; C I Johnston
Journal:  Eur J Pharmacol       Date:  1982-07-16       Impact factor: 4.432

4.  Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

Authors:  K Tatemoto; M Carlquist; V Mutt
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

5.  An analysis of excitatory junctional potentials recorded from arterioles.

Authors:  G D Hirst; T O Neild
Journal:  J Physiol       Date:  1978-07       Impact factor: 5.182

6.  Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle.

Authors:  M L Cohen; R W Fuller; K S Wiley
Journal:  J Pharmacol Exp Ther       Date:  1981-08       Impact factor: 4.030

7.  Chronic reserpine treatment alters sensitivity and membrane potential of the rabbit saphenous artery.

Authors:  P W Abel; P R Urquilla; K Goto; D P Westfall; R L Robinson; W W Fleming
Journal:  J Pharmacol Exp Ther       Date:  1981-05       Impact factor: 4.030

8.  Role of membrane potential in the response of rat small mesenteric arteries to exogenous noradrenaline stimulation.

Authors:  M J Mulvany; H Nilsson; J A Flatman
Journal:  J Physiol       Date:  1982-11       Impact factor: 5.182

9.  Excitation-contraction coupling in the smooth muscle cells of the rabbit main pulmonary artery.

Authors:  R Casteels; K Kitamura; H Kuriyama; H Suzuki
Journal:  J Physiol       Date:  1977-09       Impact factor: 5.182

10.  Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat.

Authors:  J M Lundberg; G Fried; J Pernow; E Theodorsson-Norheim
Journal:  Acta Physiol Scand       Date:  1986-02
View more
  9 in total

1.  Vasodilatation of arterioles by acetylcholine released from single neurones in the guinea-pig submucosal plexus.

Authors:  T O Neild; K Z Shen; A Surprenant
Journal:  J Physiol       Date:  1990-01       Impact factor: 5.182

2.  Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries.

Authors:  R Andriantsitohaina; J C Stoclet
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

3.  Interactions between neuropeptide Y and the adenylate cyclase pathway in rat mesenteric small arteries: role of membrane potential.

Authors:  D Prieto; C Buus; M J Mulvany; H Nilsson
Journal:  J Physiol       Date:  1997-07-15       Impact factor: 5.182

4.  Gender-modulated endogenous baseline neuropeptide Y Y1-receptor activation in the hindlimb of Sprague-Dawley rats.

Authors:  Dwayne N Jackson; Kevin J Milne; Earl G Noble; J Kevin Shoemaker
Journal:  J Physiol       Date:  2004-10-28       Impact factor: 5.182

5.  Effects of neuropeptide Y and calcitonin gene-related peptide on sheep coronary artery rings under oxygenated, hypoxic and simulated myocardial ischaemic conditions.

Authors:  Y W Kwan; R M Wadsworth; K A Kane
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

6.  Neuropeptide Y potentiates calcium-channel currents in single vascular smooth muscle cells.

Authors:  Z Xiong; B J Bolzon; D W Cheung
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

7.  Regional heterogeneity in the contractile and potentiating effects of neuropeptide Y in rat isolated coronary arteries: modulatory action of the endothelium.

Authors:  D Prieto; S Benedito; U Simonsen; N C Nyborg
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

8.  Enhancement by neuropeptide Y (NPY) of the dihydropyridine-sensitive component of the response to alpha 1-adrenoceptor stimulation in rat isolated mesenteric arterioles.

Authors:  R Andriantsitohaina; J C Stoclet
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

9.  Mechanisms of melatonin-induced vasoconstriction in the rat tail artery: a paradigm of weak vasoconstriction.

Authors:  M J Lew; S Flanders
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.